ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 39 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $2,775,000 | -31.1% | 5,904,863 | 0.0% | 0.01% | -7.1% |
Q4 2015 | $4,030,000 | -29.6% | 5,904,863 | 0.0% | 0.01% | -33.3% |
Q3 2015 | $5,728,000 | -19.2% | 5,904,863 | 0.0% | 0.02% | -8.7% |
Q2 2015 | $7,086,000 | +13.2% | 5,904,863 | 0.0% | 0.02% | +15.0% |
Q1 2015 | $6,259,000 | -2.8% | 5,904,863 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $6,436,000 | +0.9% | 5,904,863 | 0.0% | 0.02% | +5.3% |
Q3 2014 | $6,377,000 | +3.8% | 5,904,863 | 0.0% | 0.02% | +18.8% |
Q2 2014 | $6,141,000 | +1.0% | 5,904,863 | 0.0% | 0.02% | -11.1% |
Q1 2014 | $6,082,000 | -11.2% | 5,904,863 | 0.0% | 0.02% | -18.2% |
Q4 2013 | $6,850,000 | -30.9% | 5,904,863 | 0.0% | 0.02% | -45.0% |
Q3 2013 | $9,920,000 | -16.0% | 5,904,863 | 0.0% | 0.04% | -27.3% |
Q2 2013 | $11,810,000 | – | 5,904,863 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
NEXT Financial Group, Inc | 60 | $0 | 0.00% |
CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |